Clinical trial

A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone

NCT07156500

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention HS-20094 Injection Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention HS-20094 Placebo Injection Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention HS-20094 Injection Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention HS-20094 Placebo Injection Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A Phase 3 Study of HS-20094 in Patients With T2DM Inadequately Controlled With Diet and Exercise Alone

Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2025-09-30

PhasePHASE3

Conditions

Type 2 Diabetesverified · MONDO: type 2 diabetes mellitus

Interventions

HS-20094 InjectionDRUG

HS-20094 Placebo InjectionDRUG

HS-20094 InjectionDRUG

HS-20094 Placebo InjectionDRUG

Sponsors & collaborators

Jiangsu Hansoh Pharmaceutical Co., Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07156500 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.